Pandemic/Glossary

A

AE

adverse event

AEFI

adverse event following immunisation

AESI

adverse event of special interest

AR

adverse reaction

ASPR

Assistant Secretary for Preparedness and Response (U.S)

B

BARDA

Biomedical Advanced Research and Development Authority (part of the HHS Office of the Assistant Secretary for Preparedness and Response (ASPR))

C

CDC

Centers for Disease Control and Prevention (U.S)

CBRND

Chemical, Biological, Radiological and Nuclear Defense (USA)

CEPI

The Coalition for Epidemic Preparedness Innovations (CEPI) is a global partnership launched in 2017 to develop vaccines to stop future epidemics

COVID-19

CoronaVirus Disease 2019 (caused by SARS-CoV-2)

COPD

Chronic Obstructive Pulmonary Disease

D

DHS

Department of Homeland Security (USA)

DOD

Department of Defense (USA)

DNA

DeoxyriboNucleic Acid

E

ECDC

European Centre for Disease Prevention and Control

EMA

European Medicines Agency. The EMA is responsible for authorizing vaccines in the European Union (EU)

EUA

Emergency Use Authorization (USA)

EudraVigilance

European database of suspected adverse reaction reports

F

FDA

Food and Drug Administration (USA)

FEMA

Federal Emergency Management Agency (USA)

fomite

fomites

objects such as a doorknob, handrail, benchtop, or wall switch which may be contaminated with a virus (or bacteria) enabling transmission a disease by contact with the object or surface

H

HHS

Department of Health and Human Services (USA)

HIV

Human Immunodeficiency Virus

I

In vivo

In vivo is Latin for “within the living.” It refers to work that’s performed in a whole, living organism. Source

In vitro

In vitro is Latin for “within the glass.” When something is performed in vitro, it happens outside of a living organism. Source

In situ

In situ means “in its original place.” It lies somewhere between in vivo and in vitro. Something that’s performed in situ means that it’s observed in its natural context, but outside of a living organism. Source

J

JPEO-CBRND

DOD Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (USA)

JPEO

Joint Program Executive Office (USA)

L

LNP

lipid nanoparticle

M

MERS

Middle East Respiratory Syndrome

MERS-CoV

Middle East Respiratory Syndrome Coronavirus

mRNA

messenger RiboNucleic Acid

modRNA

nucleoside-modified messenger RiboNucleic Acid

O

OWS

Operation Warp Speed (USA)

P

PEG

Polyethylene glycol

PCR

polymerase chain reaction (A PCR test is used to determine if a person may be infected with SARS-CoV-2)

R

RNA

RiboNucleic Acid

S

SAE

serious adverse event

SARS

Severe Acute Respiratory Syndrome

SARS-CoV-2

Severe Acute Respiratory Syndrome CoronaVirus 2

SM-102

heptadecan-9-yl 8-((2-hydroxyethyl)(6-oxo-6-(undecyloxy)hexyl)amino)octanoate

T

TEAE

treatment-emergent adverse event

V

VAED

vaccine-associated enhanced disease

VAERD

vaccine-associated enhanced respiratory disease

VAERS

Vaccine Adverse Event Reporting System (USA)

W

WHO

World Health Organization

CoronaVirus Disease 2019 (caused by SARS-CoV-2)

adverse event

adverse event following immunisation

adverse event of special interest

adverse reaction

Assistant Secretary for Preparedness and Response (U.S)

Biomedical Advanced Research and Development Authority (part of the HHS Office of the Assistant Secretary for Preparedness and Response (ASPR))

Department of Health and Human Services (USA)

Centers for Disease Control and Prevention (U.S)

Chemical, Biological, Radiological and Nuclear Defense (USA)

The Coalition for Epidemic Preparedness Innovations (CEPI) is a global partnership launched in 2017 to develop vaccines to stop future epidemics

Severe Acute Respiratory Syndrome CoronaVirus 2

Chronic Obstructive Pulmonary Disease

Department of Homeland Security (USA)

Department of Defense (USA)

DeoxyriboNucleic Acid

European Centre for Disease Prevention and Control

European Medicines Agency. The EMA is responsible for authorizing vaccines in the European Union (EU)

European Union

Emergency Use Authorization (USA)

European database of suspected adverse reaction reports

Food and Drug Administration (USA)

Federal Emergency Management Agency (USA)

objects such as a doorknob, handrail, benchtop, or wall switch which may be contaminated with a virus (or bacteria) enabling transmission a disease by contact with the object or surface

objects such as a doorknob, handrail, benchtop, or wall switch which may be contaminated with a virus (or bacteria) enabling transmission a disease by contact with the object or surface

Human Immunodeficiency Virus

In vivo is Latin for “within the living.” It refers to work that’s performed in a whole, living organism. Source

In vitro is Latin for “within the glass.” When something is performed in vitro, it happens outside of a living organism. Source

In situ means “in its original place.” It lies somewhere between in vivo and in vitro. Something that’s performed in situ means that it’s observed in its natural context, but outside of a living organism. Source

DOD Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (USA)

Joint Program Executive Office (USA)

lipid nanoparticle

Middle East Respiratory Syndrome

Middle East Respiratory Syndrome Coronavirus

messenger RiboNucleic Acid

nucleoside-modified messenger RiboNucleic Acid

Operation Warp Speed (USA)

Polyethylene glycol

polymerase chain reaction (A PCR test is used to determine if a person may be infected with SARS-CoV-2)

RiboNucleic Acid

serious adverse event

Severe Acute Respiratory Syndrome

heptadecan-9-yl 8-((2-hydroxyethyl)(6-oxo-6-(undecyloxy)hexyl)amino)octanoate

treatment-emergent adverse event

vaccine-associated enhanced disease

vaccine-associated enhanced respiratory disease

Vaccine Adverse Event Reporting System (USA)

World Health Organization